The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA approval awaited this month . : r biotech_stocks RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica 7 FDA Headlines You Missed in January 2026 HCPLive RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion